Free Trial

Bioceres Crop Solutions (NASDAQ:BIOX) Cut to Sell at Wall Street Zen

Bioceres Crop Solutions logo with Consumer Staples background

Key Points

  • Bioceres Crop Solutions has been downgraded from a "hold" to a "sell" rating by analysts at Wall Street Zen, reflecting a shift in investor sentiment.
  • Oppenheimer has lowered its price target for the company from $7.00 to $6.00 while maintaining an "outperform" rating, amidst varying analyst views on the stock.
  • The company reported earnings of ($0.02) EPS for the last quarter, exceeding estimates, although revenue fell short of expectations at $59.60 million against a forecast of $61.80 million.
  • Need better tools to track Bioceres Crop Solutions? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Wall Street Zen cut shares of Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) from a hold rating to a sell rating in a report issued on Saturday.

Separately, Oppenheimer dropped their price target on shares of Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating for the company in a research report on Tuesday, July 15th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $8.38.

Get Our Latest Stock Report on Bioceres Crop Solutions

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX traded down $0.13 during midday trading on Friday, reaching $2.68. The company's stock had a trading volume of 215,445 shares, compared to its average volume of 209,673. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. Bioceres Crop Solutions has a fifty-two week low of $2.60 and a fifty-two week high of $11.41. The business's 50 day moving average price is $3.80 and its two-hundred day moving average price is $4.28. The company has a market cap of $167.81 million, a P/E ratio of -19.14, a P/E/G ratio of 1.19 and a beta of 0.44.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in BIOX. Jones Financial Companies Lllp raised its position in Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Jump Financial LLC acquired a new position in shares of Bioceres Crop Solutions during the fourth quarter worth $72,000. Avanza Fonder AB acquired a new position in shares of Bioceres Crop Solutions during the first quarter worth $72,000. Finally, PDT Partners LLC acquired a new position in shares of Bioceres Crop Solutions during the first quarter worth $81,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Further Reading

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Should You Invest $1,000 in Bioceres Crop Solutions Right Now?

Before you consider Bioceres Crop Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.

While Bioceres Crop Solutions currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines